According to the latest report by IMARC Group "Nanopore Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", The global nanopore technologies market reached a value of US$ 213.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 476.6 Million by 2027, exhibiting at a CAGR of 13.7% during 2022-2027.

Nanopore technologies refer to the next-generation molecule sequencing methods that are generally used for analyzing ribonucleic acid (RNA) or deoxyribonucleic acid (DNA) fragments. It involves the utilization of sequencing devices that contain nano-sized pores embedded in an electro-resistant membrane for determining the sequence and modifications of the bases. Along with this, it aids in the real-time analysis of the sequence of nucleotides with accurate data of short to long fragments of native RNA or DNA. As a result, it is extensively utilized by scientific researchers to study the biology of animals, plants, pathogens and humans.

Request for a free sample copy of this report: https://www.imarcgroup.com/nanopore-technologies-market/requestsample

Market Trends:

The global market is primarily driven by the rising demand for DNA sequencing. This is impelled by the growing need for new treatment methods due to the escalating prevalence of viral diseases among the masses. In line with this, the rapid outbreak of coronavirus disease (COVID-19) has further propelled the market growth. Since nanopore technologies offer direct molecular analysis in a time- and cost-efficient manner while generating accurate results, this is providing a boost to their uptake. Along with this, extensive research and development (R&D) activities conducted for studying novel virus variants are creating a positive market outlook. Furthermore, continual technological advancements, such as the integration of the Internet of Things (IoT) and computational intelligence with nanopore technology, are considered to be major growth-inducing factors. Additionally, the widespread adoption of nanopore technology in the development of semiconductor-based silicon molecular detectors for performing sequencing is significantly contributing to the market. Other factors, including the increasing number of research centers and laboratories, miniaturization of nanopore devices, and continuous improvements in the healthcare infrastructure, are also favorably impacting the market.

Breakup by Product:

• Instruments
  • Portable
  • Benchtop
• Consumables

Breakup by Application:

• DNA Sequencing
• RNA Sequencing
• Others

Breakup by End User:

• Hospitals and Clinics
• Research Institutes
• Others

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Competitive Landscape with Key Player:

• Agilent Technologies Inc.
• Cyclomics BV
• Electronic Biosciences Inc.
• Inanobio Inc.
• Nabsys Inc.
• Ontera Inc.
• Oxford Nanopore Technologies Limited
• Pacific Biosciences of California Inc.
• Quantapore Inc.
• Roche Holding AG
• Tracxn Technologies Limited.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4718&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal